Supplementary Figure 1 from A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring <i>hras</i> Mutations
openalex（2023）
关键词
Biomarker Analysis,Clinical Characteristics,Cancer Registry Data,Urothelial Carcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要